Denali Therapeutics (DNLI) Net Margin (QoQ) (2018 - 2023)

Denali Therapeutics (DNLI) Net Margin (QoQ) (2018 - 2023) Analysis & Trends

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Oculis Holding AG 68,785.72 Bn 68,785.72 Bn -
2 Nanobiotix 1,895.57 Bn 1,895.51 Bn -
3 BeOne Medicines 471.35 Bn 466.56 Bn 1.35 Bn
4 NuCana 279.75 Bn 279.75 Bn -
5 Vertex Pharmaceuticals 120.24 Bn 113.00 Bn 2.59 Bn
6 Regeneron Pharmaceuticals 67.80 Bn 59.04 Bn 3.31 Bn
7 Belite Bio 62.51 Bn 62.51 Bn -
8 Argenx Se 57.38 Bn 57.38 Bn 1.41 Bn
9 Revolution Medicines 37.78 Bn 37.78 Bn -
10 Denali Therapeutics 4.37 Bn 4.37 Bn -

Historic Data

Download Data
DateValue
Sep 30, 2023 -790,394.00
Jun 30, 2023 38,328.00
Mar 31, 2023 66,585.00
Dec 31, 2022 207,393.00
Sep 30, 2022 -294,868.00
Jun 30, 2022 5,198.00
Mar 31, 2022 -932.00
Dec 31, 2021 144,584.00
Sep 30, 2021 -119,592.00
Jun 30, 2021 47,953.00
Mar 31, 2021 -96,143.00
Dec 31, 2020 69,754.00
Sep 30, 2020 39,091.00
Jun 30, 2020 10.82 Mn
Mar 31, 2020 -10.56 Mn
Dec 31, 2019 -258,560.00
Sep 30, 2019 36,036.00
Jun 30, 2019 -49,627.00
Mar 31, 2019 -98,897.00
Dec 31, 2018 302,161.00